Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Nov 25;13:488.
doi: 10.1186/1472-6963-13-488.

Medication Adherence in HIV-positive Patients With Diabetes or Hypertension: A Focus Group Study

Affiliations
Free PMC article

Medication Adherence in HIV-positive Patients With Diabetes or Hypertension: A Focus Group Study

Anne K Monroe et al. BMC Health Serv Res. .
Free PMC article

Abstract

Background: People with HIV are living longer with potent antiretroviral therapy (ART), and HIV is increasingly complicated by other chronic medical comorbidities. The objective of this study was to explore HIV-positive patients' perspectives on living with HIV and diabetes mellitus (DM) or hypertension (HTN) and factors affecting medication adherence.

Methods: We conducted six focus groups. Two investigators independently coded transcripts for thematic content using editing style analysis. Codes were grouped into conceptual themes using consensus process.

Results: Thirty-five HIV-positive patients with diabetes or hypertension participated. Four major themes emerged: (1) Comorbidities are a source of concern and frustration, sometimes eclipsing concern regarding HIV (2) Understanding of health conditions and medications promotes adherence, (3) Simpler regimens with fewer side effects promote adherence, and (4) Untreated substance abuse and mental health issues hinder adherence.

Conclusions: HIV-positive patients in this study voiced concern regarding medical comorbidities and highlighted patient understanding, regimen factors, and substance abuse/mental health issues as barriers to adherence. Addressing these issues may improve outcomes in the aging HIV-positive population. Adherence to medications among HIV-positive patients with DM or HTN may be influenced by providing targeted disease-specific education, simplifying regimens, and treatment of substance abuse/mental health issues.

Similar articles

See all similar articles

Cited by 13 articles

See all "Cited by" articles

References

    1. Sterne JAC, Hernán MA, Ledergerber B, Tilling K, Weber R, Sendi P, Rickenbach M, Robins J, Egger M. Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. Lancet. 2005;13:378–384. - PubMed
    1. Barbaro G. Highly active antiretroviral therapy-associated metabolic syndrome: pathogenesis and cardiovascular risk. Am J Ther. 2006;13:248–260. - PubMed
    1. De Wit S, Sabin CA, Weber R, Worm SW, Reiss P, Cazanave C, El-Sadr W, Monforte A, Fontas E, Law MG, Friis-Møller N, Phillips A. Incidence and risk factors for New-onset diabetes in HIV-infected patients. Diabetes Care. 2008;13:1224–1229. - PMC - PubMed
    1. Brown TT, Cole SR, Li X, Kingsley LA, Palella FJ, Riddler SA, Visscher BR, Margolick JB, Dobs AS. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med. 2005;13:1179–1184. - PubMed
    1. Baekken M, Os I, Sandvik L, Oektedalen O. Hypertension in an urban HIV-positive population compared with the general population: influence of combination antiretroviral therapy. J Hypertens. 2008;13:2126–2133. - PubMed

Publication types

MeSH terms

Substances

Feedback